It's confusing isn't it
So what we have in pre-clinical trials
Dep Docetaxel has been used in combination with Gemcitabine
Dep Cabazitaxel has been used in combination with Gemcitabine
DEP® gemcitabine has been used alone in studies
DEP® gemcitabine has been used in combination with Abraxane®
What are Starpharma's intention in human clinical trials
Shortly gemcitabine will be used in combination with Dep Docetaxel
DEP® gemcitabine has been filed at patent office
I am assuming this will be in the clinic sometime soon
Hope this clears things up
Gemcitabine and Dep Docetaxel and Dep Cabazitaxel and Dep Gemcitabine
Add SPL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.15 |
Change
0.010(0.47%) |
Mkt cap ! $872.9M | |||
| Open | High | Low | Value | Volume |
| $2.10 | $2.15 | $2.06 | $1.673M | 794.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 25071 | $2.14 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.16 | 11297 | 1 |
View Market Depth
| Last trade - 16.11pm 25/02/2021 (20 minute delay) ? |
 (live)
|
|||||
|
Last
$2.14 |
Change
0.010 ( 0.66 %) |
||||
| Open | High | Low | Volume | ||
| $2.08 | $2.15 | $2.06 | 138973 | ||
| Last updated 15.59pm 25/02/2021 (live) ? | |||||
| SPL (ASX) Chart |